Related Experiment Video
Updated: Jun 23, 2025
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.8K
Interplay between diabetes mellitus and atopic dermatitis
Dongyun Lei1, Jiechen Zhang2, Tingting Zhu3
1Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Experimental Dermatology
|June 18, 2024
Summary
Atopic dermatitis (AD) and diabetes mellitus share complex links, with studies showing both increased and decreased diabetes risk in AD patients. Understanding these interactions is key for managing both conditions.
Area of Science:
- Dermatology and Endocrinology
- Immunology and Metabolism
Background:
- Atopic dermatitis (AD), a common inflammatory skin condition, is increasingly recognized for its association with diabetes mellitus.
- Existing research presents conflicting findings, with some studies indicating an elevated risk of diabetes in AD patients, while others report a lower prevalence.
Purpose of the Study:
- To review the existing evidence on the bidirectional relationship between diabetes mellitus and atopic dermatitis.
- To explore the potential underlying mechanisms driving the interaction between these two distinct conditions.
Main Methods:
- Literature review of studies investigating the link between atopic dermatitis and diabetes mellitus.
- Analysis of proposed mechanisms, including genetic, environmental, and immunological factors.
Main Results:
- Evidence suggests a complex interplay between AD and diabetes, influenced by factors like cytokines and epidermal dysfunction.
- Treatment of AD may impact the development or progression of diabetes, and vice versa.
Conclusions:
- The reciprocal influence between diabetes mellitus and atopic dermatitis is multifactorial, involving genetic predispositions, environmental exposures, and therapeutic interventions.
- Effective management of either condition holds potential for mitigating the impact of the other, highlighting the need for integrated care approaches.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:20Pathophysiology of Diabetes
919
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
919
01:15Diabetes: Symptoms, Diagnosis, and Complications
522
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
522
01:29Autoimmune Disorders
415
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
415
01:16Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165